Cargando…

Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics

Detalles Bibliográficos
Autores principales:	Comi, Cristoforo, Cosentino, Marco, Pacheco, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804273/ https://www.ncbi.nlm.nih.gov/pubmed/31681151 http://dx.doi.org/10.3389/fneur.2019.01080

Ejemplares similares

The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease
por: Martini, Stefano, et al.
Publicado: (2023)

Editorial: Role of Diet, Physical Activity and Immune System in Parkinson's Disease
por: Albani, Giovanni, et al.
Publicado: (2020)

Editorial: Neuroimaging in Parkinson's disease and Parkinsonism
por: Zhang, Yu, et al.
Publicado: (2023)

Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy
por: Fleetwood, Thomas, et al.
Publicado: (2018)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

Editorial: Prodromal Parkinson's Disease
por: Crosiers, David, et al.
Publicado: (2021)

Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy
por: Fan, Baoyan, et al.
Publicado: (2020)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
por: Filippi, Massimo, et al.
Publicado: (2023)

Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson’s Disease: A Single-Center Longitudinal Study
por: Contaldi, Elena, et al.
Publicado: (2022)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

Editorial: Updates on inflammation in Parkinson's disease
por: Dzamko, Nicolas, et al.
Publicado: (2023)

The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey
por: Martini, Stefano, et al.
Publicado: (2022)

Editorial: Fatigue in multiple sclerosis—A current perspective
por: Pokryszko-Dragan, Anna, et al.
Publicado: (2023)

Editorial: Emerging Ototoxic Medications and Their Role in Cochlear and Vestibular Disorders
por: Szczepek, Agnieszka J., et al.
Publicado: (2021)

Editorial: Anesthetic neurotoxicity in developing brains: mechanisms, biomarkers, and therapeutic targets
por: Yu, Yang, et al.
Publicado: (2023)

Editorial: Surgical treatment of peripheral neuropathic pain, peripheral nerve tumors, and peripheral nerve injury
por: Dong, Yanzhao, et al.
Publicado: (2023)

Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2021)

The Emerging Role of RHOT1/Miro1 in the Pathogenesis of Parkinson's Disease
por: Grossmann, Dajana, et al.
Publicado: (2020)

Editorial: Inflammation in ischemic stroke and novel therapeutic strategies for stroke treatment
por: Marei, Hany E., et al.
Publicado: (2022)

Editorial: Managing Parkinson's Disease With a Multidisciplinary Perspective
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2021)

Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence
por: Storelli, Elisa, et al.
Publicado: (2019)

Editorial: Cerebrovascular and Neurodegenerative Diseases - New Insights Into Molecular Cell Biology and Therapeutic Targets
por: Saha, Sikha, et al.
Publicado: (2019)

Peripheral blood monocytes as a therapeutic target for marrow stromal cells in stroke patients
por: Satani, Nikunj, et al.
Publicado: (2022)

Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
por: Magistrelli, Luca, et al.
Publicado: (2021)

Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders
por: Rahman, Md. Mominur, et al.
Publicado: (2023)

Editorial: Parkinson's disease: Technological trends for diagnosis and treatment improvement
por: Cabestany, Joan, et al.
Publicado: (2023)

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
por: White, Alice J., et al.
Publicado: (2018)

Editorial: Complex Scenarios of Drug-Resistant Epilepsies: Diagnostic Challenges and Novel Therapeutic Options
por: Didato, Giuseppe, et al.
Publicado: (2022)

Editorial: New insights into the treatment of aneurysms with flow diverters: novel indications and therapeutic advances
por: Zhou, Yu, et al.
Publicado: (2023)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Editorial: Emerging talents in: sleep disorders
por: Thannickal, Thomas Chacko, et al.
Publicado: (2023)

Editorial: Impulse Control Disorders, Impulsivity and Related Behaviors in Parkinson's Disease
por: Rodríguez-Violante, Mayela, et al.
Publicado: (2019)

Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease
por: Farrer, Matthew J., et al.
Publicado: (2021)

Editorial: Measurement Tools for Clinical Assessment, Characterization and Neurorehabilitation of Parkinson's Disease
por: Rodriguez-Blazquez, Carmen, et al.
Publicado: (2021)

Editorial: Integrated Motor-Cognitive Aerobic Rehabilitation Approaches in Parkinson's Disease
por: Canesi, Margherita, et al.
Publicado: (2021)

T Lymphocytes in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2022)

Editorial: Use of Ultrasound in Diagnosis and Treatment of Peripheral Nerve Entrapment Syndrome
por: Chang, Ke-Vin, et al.
Publicado: (2020)

Editorial: Application of ultrasound on peripheral neuromuscular disorders: From anatomy to clinic
por: Chang, Ke-Vin, et al.
Publicado: (2023)

Bilateral Repetitive Transcranial Magnetic Stimulation With the H-Coil in Parkinson's Disease: A Randomized, Sham-Controlled Study
por: Spagnolo, Francesca, et al.
Publicado: (2021)

Editorial: Advances in Therapeutics for Hyperkinetic Movement Disorders
por: Klopstock, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7vo3dilr9vja5prv5s4k3o5e0v